Centogene N.V. (CNTGF)

OTCMKTS · Delayed Price · Currency is USD
0.0710
-0.0100 (-12.35%)
Aug 29, 2025, 4:00 PM EDT
-12.35%
Market Cap2.12M
Revenue (ttm)53.65M
Net Income (ttm)-39.27M
Shares Out29.82M
EPS (ttm)-1.40
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume100
Average Volume1,249
Open0.0710
Previous Close0.0810
Day's Range0.0710 - 0.0710
52-Week Range0.0100 - 0.7050
Beta-0.02
RSI49.24
Earnings DateSep 5, 2025

About Centogene

Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA sequencing, biochemical testing, and RNA sequencing; CentoCloud, a cloud-based Software as a Service platform, which enables laboratories to analyze, i... [Read more]

Sector Healthcare
Founded 2006
Employees 384
Stock Exchange OTCMKTS
Ticker Symbol CNTGF
Full Company Profile

Financial Performance

In 2023, Centogene's revenue was 48.54 million, an increase of 2.24% compared to the previous year's 47.47 million. Losses were -35.53 million, 11.6% more than in 2022.

Financial numbers in EUR Financial Statements

News

There is no news available yet.